Xendo CEO André van de Sande moderating a session about Strategies for growth for Life Sciences companies at the recent Dutch Biotech Event. Synthon and Merus shared their insights about their successful company strategies.
Kirsten Lingbeek is a pharmacist by education, she joined Xendo in 2012 and is currently leading the departments based in the Netherlands as COO. She started her career in the hospital pharmacy, after which she joined Solvay Pharmaceuticals (now Abbott Healthcare), starting as production Pharmacist for IMPs. She has been CMC project lead for a phase III program and registered QP for IMPs. She has set up, led and developed a global department, with the responsibility for the complete Clinical Supply Chain: drug substance, drug product, packaging and
Compliance with Good Manufacturing Practice (GMP), Good Distribution Practice (GDP), Good Clinical Practice (GCP) and ISO standards is compulsory in the pharmaceutical, medical device
Schipholweg 73 – 75
P.O. Box 255, 2300 AG Leiden, The Netherlands
tel +31 (0)71 524 40 00 - fax +31 (0)71 524 40 01